Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation

Innate immune receptors NOD1 and NOD2 are activated by bacterial peptidoglycans leading to recruitment of adaptor kinase RIP2, which, upon phosphorylation and ubiquitination, becomes a scaffold for downstream effectors. The kinase domain (RIP2K) is a pharmaceutical target for inflammatory diseases caused by aberrant NOD2-RIP2 signalling. Although structures of active RIP2K in complex with inhibitors have been reported, the mechanism of RIP2K activation remains to be elucidated. Here we analyse RIP2K activation by combining crystal structures of the active and inactive states with mass spectrometric characterization of their phosphorylation profiles. The active state has Helix αC inwardly displaced and the phosphorylated Activation Segment (AS) disordered, whilst in the inactive state Helix αC is outwardly displaced and packed against the helical, non-phosphorylated AS. Biophysical measurements show that the active state is a stable dimer whilst the inactive kinase is in a monomer-dimer equilibrium, consistent with the observed structural differences at the dimer interface. We conclude that RIP2 kinase auto-phosphorylation is intimately coupled to dimerization, similar to the case of BRAF. Our results will help drug design efforts targeting RIP2 as a potential treatment for NOD2-RIP2 related inflammatory diseases.

[1]  Albert J R Heck,et al.  Improving the performance of a quadrupole time-of-flight instrument for macromolecular mass spectrometry. , 2006, Analytical chemistry.

[2]  M. Kopf,et al.  The Kinase Activity of Rip2 Determines Its Stability and Consequently Nod1- and Nod2-mediated Immune Responses* , 2009, The Journal of Biological Chemistry.

[3]  D. Jewell,et al.  NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.

[4]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[5]  J. Kuriyan,et al.  Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms. , 2011, Molecular cell.

[6]  A. Nairn,et al.  Oligomerization states of the association domain and the holoenyzme of Ca2+/CaM kinase II , 2006, The FEBS journal.

[7]  N. Warner,et al.  The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. , 2011, Trends in immunology.

[8]  P. Cohen,et al.  Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. , 2007, The Biochemical journal.

[9]  Dirar Homouz,et al.  Structure, function, and folding of phosphoglycerate kinase are strongly perturbed by macromolecular crowding , 2010, Proceedings of the National Academy of Sciences.

[10]  L. Peso,et al.  Erratum: RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates cd95-mediated apoptosis (Journal of Biological Chemistry (1998) 273 (12296-12300)) , 1998 .

[11]  D. Kern,et al.  Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2 , 2014, eLife.

[12]  Christian Morawe,et al.  The ID23-2 structural biology microfocus beamline at the ESRF , 2009, Journal of synchrotron radiation.

[13]  A. Shevchenko,et al.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.

[14]  A. Degterev,et al.  Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors , 2015, Chemistry & biology.

[15]  Hao Wu,et al.  IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly. , 2014, Molecular cell.

[16]  J. Sandow,et al.  A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production , 2015, Nature Communications.

[17]  D. Engelberg,et al.  How Do Protein Kinases Take a Selfie (Autophosphorylate)? , 2016, Trends in biochemical sciences.

[18]  L. del Peso,et al.  RICK, a Novel Protein Kinase Containing a Caspase Recruitment Domain, Interacts with CLARP and Regulates CD95-mediated Apoptosis* , 1998, The Journal of Biological Chemistry.

[19]  Susan S. Taylor,et al.  Integration of signaling in the kinome: Architecture and regulation of the αC Helix. , 2015, Biochimica et biophysica acta.

[20]  J. Bunkenborg,et al.  Quantitation of multisite EGF receptor phosphorylation using mass spectrometry and a novel normalization approach. , 2007, Journal of proteome research.

[21]  Susan S. Taylor,et al.  Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism , 2006, Proceedings of the National Academy of Sciences.

[22]  Virgil L. Woods,et al.  A conserved Glu-Arg salt bridge connects coevolved motifs that define the eukaryotic protein kinase fold. , 2012, Journal of molecular biology.

[23]  C. Robinson,et al.  A tandem mass spectrometer for improved transmission and analysis of large macromolecular assemblies. , 2002, Analytical chemistry.

[24]  G. Núñez,et al.  Nod1/RICK and TLR Signaling Regulate Chemokine and Antimicrobial Innate Immune Responses in Mesothelial Cells1 , 2007, The Journal of Immunology.

[25]  A. Chinnaiyan,et al.  A Dual Role for Receptor-interacting Protein Kinase 2 (RIP2) Kinase Activity in Nucleotide-binding Oligomerization Domain 2 (NOD2)-dependent Autophagy* , 2012, The Journal of Biological Chemistry.

[26]  E. O’Shea,et al.  The Innate Immune Protein Nod2 Binds Directly to MDP, a Bacterial Cell Wall Fragment , 2012, Journal of the American Chemical Society.

[27]  Carol A. Capriotti,et al.  The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase. , 2016, Journal of medicinal chemistry.

[28]  D. Philpott,et al.  Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry , 2010, Nature Immunology.

[29]  L. Signor,et al.  Matrix-assisted Laser Desorption/Ionization Time of Flight (MALDI-TOF) Mass Spectrometric Analysis of Intact Proteins Larger than 100 kDa , 2013, Journal of visualized experiments : JoVE.

[30]  V. Dixit,et al.  RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase* , 1998, The Journal of Biological Chemistry.

[31]  Xiaodong Bai,et al.  In Vivo Inhibition of RIPK2 Kinase Alleviates Inflammatory Disease* , 2014, The Journal of Biological Chemistry.

[32]  Susan S. Taylor,et al.  Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers , 2013, Cell.

[33]  T. Nakahata,et al.  Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. , 2009, Arthritis and rheumatism.

[34]  Owen Johnson,et al.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM , 2011, Acta crystallographica. Section D, Biological crystallography.

[35]  S. Foster,et al.  Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.

[36]  D. Baldwin,et al.  RIP2 Is a Raf1-activated Mitogen-activated Protein Kinase Kinase* , 1999, The Journal of Biological Chemistry.

[37]  D. Jewell,et al.  NOD2 (CARD15), the first susceptibility gene for Crohn's disease , 2001, Gut.

[38]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[39]  M. Chamaillard,et al.  Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.

[40]  C. Petosa,et al.  The emerging role of native mass spectrometry in characterizing the structure and dynamics of macromolecular complexes , 2015, Protein science : a publication of the Protein Society.

[41]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[42]  P. Sansonetti,et al.  Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment , 2011, EMBO molecular medicine.

[43]  Marc Therrien,et al.  A dimerization-dependent mechanism drives RAF catalytic activation , 2009, Nature.

[44]  Zhi-Xin Wang,et al.  Structural insights into the autoactivation mechanism of p21-activated protein kinase. , 2011, Structure.

[45]  Maureen A. McGargill,et al.  TLR2 and RIP2 Pathways Mediate Autophagy of Listeria monocytogenes via Extracellular Signal-regulated Kinase (ERK) Activation* , 2011, The Journal of Biological Chemistry.

[46]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[47]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[48]  C. Robinson,et al.  Massign: an assignment strategy for maximizing information from the mass spectra of heterogeneous protein assemblies. , 2012, Analytical chemistry.

[49]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[50]  Marc Therrien,et al.  Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation , 2014, Nature Structural &Molecular Biology.

[51]  F. Martinon,et al.  Identification of CARDIAK, a RIP-like kinase that associates with caspase-1 , 1998, Current Biology.

[52]  Chafen Lu,et al.  Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2. , 2006, Cellular signalling.

[53]  Didier Nurizzo,et al.  The ID23-1 structural biology beamline at the ESRF. , 2006, Journal of synchrotron radiation.

[54]  J. Hampe,et al.  CARD15 gene mutations in sarcoidosis , 2003, European Respiratory Journal.

[55]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[56]  G. Thomas,et al.  CARD15 mutations in Blau syndrome , 2001, Nature Genetics.

[57]  A. Utani,et al.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. , 2004, Blood.

[58]  D. Philpott,et al.  Essential role of Rip2 in the modulation of innate and adaptive immunity triggered by Nod1 and Nod2 ligands , 2011, European journal of immunology.

[59]  N. Jura,et al.  Structural Basis for the Non-catalytic Functions of Protein Kinases. , 2016, Structure.

[60]  Angus C. Nairn,et al.  Structure of the Autoinhibited Kinase Domain of CaMKII and SAXS Analysis of the Holoenzyme , 2005, Cell.

[61]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  Michelle C. Schaeffer,et al.  Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis. , 2013, ACS medicinal chemistry letters.

[63]  W. Wong,et al.  Receptor-Interacting Protein 2 Gene Silencing Attenuates Allergic Airway Inflammation , 2013, The Journal of Immunology.

[64]  L. Silengo,et al.  Systematic Analysis of the Epidermal Growth Factor Receptor by Mass Spectrometry Reveals Stimulation-dependent Multisite Phosphorylation*S , 2005, Molecular & Cellular Proteomics.

[65]  Xinqi Gong,et al.  Structural insights into RIP3-mediated necroptotic signaling. , 2013, Cell reports.

[66]  K Henrick,et al.  Electronic Reprint Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions Biological Crystallography Secondary-structure Matching (ssm), a New Tool for Fast Protein Structure Alignment in Three Dimensions , 2022 .

[67]  Susan S. Taylor,et al.  Defining the Conserved Internal Architecture of a Protein Kinase , 2010, Biochimica et biophysica acta.

[68]  P. Schuck,et al.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. , 2000, Biophysical journal.

[69]  Gabriel Núñez,et al.  The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. , 2008, Cancer research.

[70]  Philip Hardwicke,et al.  Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity. , 2015, Bioorganic & medicinal chemistry.

[71]  J. Asara,et al.  Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses. , 2010, Genes & development.

[72]  Philip Rosenstiel,et al.  NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. , 2013, The Journal of clinical investigation.

[73]  G. Núñez,et al.  RICK/RIP2 Mediates Innate Immune Responses Induced through Nod1 and Nod2 but Not TLRs1 , 2007, The Journal of Immunology.

[74]  J. Bertin,et al.  The immune receptor NOD1 and kinase RIP2 interact with bacterial peptidoglycan on early endosomes to promote autophagy and inflammatory signaling. , 2014, Cell host & microbe.

[75]  G. Núñez,et al.  NOD-like receptors: role in innate immunity and inflammatory disease. , 2009, Annual review of pathology.

[76]  Douglas Golenbock,et al.  The history of Toll-like receptors — redefining innate immunity , 2013, Nature Reviews Immunology.

[77]  Florian Gnad,et al.  Large-scale Proteomics Analysis of the Human Kinome , 2009, Molecular & Cellular Proteomics.